Most patients with CDK19 pathogenic variants exhibit epilepsy, including infantile spasms, hypotonia, ataxia, developmental delay/severe intellectual disability, central nervous system (CNS) changes on MRI (brain atrophy, delayed myelination), and craniofacial dysmorphisms. This evidence concerns the gene CDK19 and Global developmental delay.